Table S1 - Role of Serum Vaspin in Progression of Type 2 Diabetes: A 2-Year Cohort Study

Basic clinical characteristics of all subjects at baseline. Note: BMI: body mass index; WHR: waist-hip ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; BUN: blood urea nitrogen; TC: total cholesterol; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low density lipoprotein-cholesterol; FPG: fasting plasma glucose; 2h-PG: 2-h postprandial plasma glucose; HbA1c: glycosylated haemoglobin A1c; HOMA-IR: homeostasis model assessment of insulin resistance;*logarithmically transformed before analysis. Adjusted P values were from covariance analysis by adjusting for age, sex and BMI.
(DOC)

所有受试者基线时的基础临床特征。注：BMI为体重指数（body mass index）；WHR为腰臀比（waist-hip ratio）；SBP为收缩压（systolic blood pressure）；DBP为舒张压（diastolic blood pressure）；BUN为血尿素氮（blood urea nitrogen）；TC为总胆固醇（total cholesterol）；TG为甘油三酯（triglycerides）；HDL-C为高密度脂蛋白胆固醇（high-density lipoprotein cholesterol）；LDL-C为低密度脂蛋白胆固醇（low density lipoprotein-cholesterol）；FPG为空腹血浆葡萄糖（fasting plasma glucose）；2h-PG为餐后2小时血浆葡萄糖（2-h postprandial plasma glucose）；HbA1c为糖化血红蛋白（glycosylated haemoglobin A1c）；HOMA-IR为胰岛素抵抗稳态模型评估（homeostasis model assessment of insulin resistance）；*分析前需进行对数转换。校正后的P值通过协方差分析计算，校正因素包括年龄、性别及体重指数（BMI）。（DOC）